Currently out of the existing stock ratings of Ghansham Panjabi, 93 are a HOLD (34.7%), 175 are a BUY (65.3%).

Ghansham Panjabi

Work Performance Price Targets & Ratings Chart

Analyst Ghansham Panjabi, currently employed at BAIRD, carries an average stock price target met ratio of 71.28% that have a potential upside of 30.57% achieved within 449 days.

Ghansham Panjabi’s has documented 542 price targets and ratings displayed on 26 stocks. The coverage is on Consumer Cyclical, Basic Materials, Industrials, Healthcare, Technology sectors.

Most recent stock forecast was given on SON, Sonoco Products Company at 23-Apr-2026.

Wall Street Analyst Ghansham Panjabi

Analyst best performing recommendations are on ATRA (ATARA BIOTHERAPEUTICS).
The best stock recommendation documented was for ATRA (ATARA BIOTHERAPEUTICS) at 8/1/2022. The price target of $110 was fulfilled within 8 days with a profit of $38.75 (54.39%) receiving and performance score of 67.98.

Average potential price target upside

of $336.08 (70.1%) on ATRA (ATARA BIOTHERAPEUTICS).
of $57.7 (171.43%) on BE (BLOOM ENERGY CORP).
of $31.96 (16.96%) on SHW (SHERWIN-WILLIAMS CO).

ATR AptarGroup BERY Berry Global Group BLL Ball CE Celanese FUL H B Fuller Company GPK Graphic Packaging Holding Company OI O-I Glass PPG PPG Industries PTVE Pactiv Evergreen RPM RPM International SEE Sealed Air SHW Sherwin-Williams Co SON Sonoco Products Company AVY Avery Dennison Corp AXTA Axalta Coating Systems Ltd GEF Greif Bros CCK Crown Holdings BALL Ball IFF International Flavors & Fragrances PACK Ranpak Holdings Corp SLGN Silgan Holdings SXT Sensient Technologies AMCR Amcor PLC ATRA Atara Biotherapeutics BE Bloom Energy Corp BL Blackline

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Gabe Hajde (WELLS FARGO)